Literature DB >> 31259879

Fluconazole Exposure in Plasma and Bile During Continuous Venovenous Hemodialysis.

Mehdi Oualha1,2, Jean-Marc Tréluyer1,2,3, Despina Moshous1,4, Marie-Elisabeth Bougnoux1,5, Julie Starck1, Sylvain Renolleau1, Inès Gana3, Sihem Benaboud1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31259879     DOI： 10.1097/FTD.0000000000000641

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.

Authors:  Samuel Dubinsky; Kevin Watt; Steven Saleeb; Bilal Ahmed; Caitlin Carter; Cindy H T Yeung; Andrea Edginton
Journal:  Clin Pharmacokinet       Date:  2021-11-30       Impact factor: 6.447

2.  Antimicrobial Dosing Recommendations in Pediatric Continuous Renal Replacement Therapy: A Critical Appraisal of Current Evidence.

Authors:  Gideon Stitt; Samuel Dubinsky; Andrea Edginton; Yuan-Shung V Huang; Athena F Zuppa; Kevin Watt; Kevin Downes
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

3.  Analysis of Related Factors of Early Mortality in Patients with Severe Renal Injury Treated with Continuous Venovenous Hemodialysis.

Authors:  Qingyun Wang; Jia Liu; Chengquan Zhai; Juan Liu
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

4.  Anti-infective Medicines Use in Children and Neonates With Pre-existing Kidney Dysfunction: A Systematic Review.

Authors:  Chiara Minotti; Elisa Barbieri; Denis Doni; Cristina Impieri; Carlo Giaquinto; Daniele Donà
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.569

Review 5.  Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.

Authors:  Lu Li; Xin Li; Yanzhe Xia; Yanqi Chu; Haili Zhong; Jia Li; Pei Liang; Yishan Bu; Rui Zhao; Yun Liao; Ping Yang; Xiaoyang Lu; Saiping Jiang
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.